NSPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
InspireMD Inc (NSPR) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators are bearish, options data shows no significant trading sentiment, and there are no positive catalysts in the news. While the company has shown revenue growth, its financial performance still reflects significant losses. The lack of strong trading signals and the ongoing investigation further suggest caution.
The technical indicators are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 29.244, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with the next support at 1.292.
Revenue increased by 61.57% YoY in Q4 2025, and gross margin improved by 55.74% YoY.
The company is under investigation for potential fiduciary breaches, and EPS dropped by -26.32% YoY. Additionally, the stock has a low probability of significant short-term gains based on historical trends.
In Q4 2025, revenue increased to $3,149,000 (up 61.57% YoY), net income improved to -$11,761,000 (up 28.20% YoY), and gross margin increased to 37.47% (up 55.74% YoY). However, EPS dropped to -0.14 (down -26.32% YoY), reflecting ongoing financial challenges.
Maxim initiated coverage with a Buy rating and a $6 price target on 2026-02-02. However, no recent updates or changes in analyst ratings are available.
